 The full value of vaccines assessments, FVVA, framework was developed to address the challenges faced when developing and introducing vaccines in low and middle income countries. It seeks to provide a comprehensive understanding of the value of vaccines, including both direct health outcomes and indirect benefits such as reduced morbidity and mortality, improved quality of life, and increased productivity. Additionally, it encourages collaboration between stakeholders to identify and prioritize vaccines that will have the greatest impact on public health. This article was authored by Raymond Huchabessy, Jeremy A. Lauer, Birgit Kiesing, and others.